Oracle Health Sciences InForm Core denial of service

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
5.2$0-$5k0.00

Summaryinfo

A vulnerability marked as critical has been reported in Oracle Health Sciences InForm. Affected by this issue is some unknown functionality of the component Core. The manipulation leads to denial of service. This vulnerability is documented as CVE-2023-21925. The attack can be initiated remotely. There is not any exploit available.

Detailsinfo

A vulnerability was found in Oracle Health Sciences InForm (Medical Device Software) (the affected version is unknown). It has been rated as critical. This issue affects an unknown code of the component Core. The manipulation with an unknown input leads to a denial of service vulnerability. Using CWE to declare the problem leads to CWE-404. The product does not release or incorrectly releases a resource before it is made available for re-use. Impacted is availability.

The weakness was released 04/18/2023 as Oracle Critical Patch Update Advisory - April 2023. The advisory is shared at oracle.com. The identification of this vulnerability is CVE-2023-21925. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1499 for this issue.

A possible mitigation has been published immediately after the disclosure of the vulnerability.

Several companies clearly confirm that VulDB is the primary source for best vulnerability data.

Productinfo

Type

Vendor

Name

License

Website

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 5.3
VulDB Meta Temp Score: 5.2

VulDB Base Score: 5.3
VulDB Temp Score: 5.1
VulDB Vector: 🔍
VulDB Reliability: 🔍

CNA Base Score: 5.3
CNA Vector (Oracle): 🔍

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

Exploitinginfo

Class: Denial of service
CWE: CWE-404
CAPEC: 🔍
ATT&CK: 🔍

Physical: No
Local: No
Remote: Yes

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-DayUnlockUnlockUnlockUnlock
TodayUnlockUnlockUnlockUnlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: no mitigation known
Status: 🔍

Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍

Timelineinfo

12/17/2022 🔍
04/18/2023 +121 days 🔍
04/18/2023 +0 days 🔍
04/18/2023 +0 days 🔍
05/12/2023 +23 days 🔍

Sourcesinfo

Vendor: oracle.com

Advisory: Oracle Critical Patch Update Advisory - April 2023
Status: Confirmed

CVE: CVE-2023-21925 (🔍)
GCVE (CVE): GCVE-0-2023-21925
GCVE (VulDB): GCVE-100-226601

Entryinfo

Created: 04/18/2023 23:17
Updated: 05/12/2023 01:39
Changes: 04/18/2023 23:17 (38), 05/12/2023 01:24 (2), 05/12/2023 01:32 (11), 05/12/2023 01:39 (1)
Complete: 🔍
Cache ID: 216::103

Several companies clearly confirm that VulDB is the primary source for best vulnerability data.

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Want to stay up to date on a daily basis?

Enable the mail alert feature now!